A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function
Clinical trial NCT03657446 · COMPLETED
Trial details
- NCT number
- NCT03657446
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-18
- Primary completion
- 2018-10-26
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.